In a significant initiative for drug safety and regulatory efficiency, the Gujarat Food and Drug Control Administration (FDCA) will procure...
Akums Drugs & Pharmaceuticals Ltd., India's leading contract development and manufacturing organization (CDMO), has announced the launch of a pioneering Ripasudil-Timolol combination therapy for glaucoma treatment.
Multinational company Anteris Technologies Global Corp, is a head in Structural heart solutions, and it has reached an essential achievement with its DurAVR Transcatheter Heart valve(THV). Over 100 patients suffering from severe aortic stenosis
Sun Pharma Advanced Research business Ltd (SPARC), a biopharmaceutical business in the clinical stage, said that it has submitted an Investigational New Drug (IND) application to the FDA in the United States.
By introducing the indigenous MRI machine, a quantum leap has now been initiated for India in the fields of healthcare and medical technology. The Made-in-India MRI scanner is set to be installed by...
.jpg)
In an interaction with India Pharma Outlook, Arushi Jain, Director at Akums Drugs & Pharmaceuticals Limited, discussed India’s growing nutraceutical sector, driven by rising health awareness and chronic diseases. She highlighted its integration with
Zydus Lifesciences Limited has established itself as a strong player in the world oncology market with its recent FDA approval to manufacture and sell a generic version of Apalutamide 60 mg tablets for the treatment of prostate cancer. The drug will
Chronic Kidney Disease (CKD) is a growing public health crisis in India, affecting a significant percentage of the population and causing over 100,000 new cases of kidney failure annually. Despite its prevalence, early detection remains low, often le
The Central Drugs Standard Control Organization (CDSCO) issued a report that, in February 2025, a total of 145 drug samples tested throughout India were found to be of a different quality standard. The increase in the NSQ reports is attributed...
Sanofi Healthcare India has received marketing authorization for Rezurock (belumosudil tablets) in India for the treatment of chronic Graft-versus-host disease (cGVHD) in patients aged 12 years and above.Rezurock is used globally for cGVHD pati...
, CDSCO.jpg)
